Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Stepan A. Pyankov"'
Autor:
Ekaterina I. Krivosheina, Mikhail Y. Kartashov, Ekaterina V. Naidenova, Nikita D. Ushkalenko, Stepan A. Pyankov, Vladimir A. Ternovoi, Valery B. Loktev
Publikováno v:
Вопросы вирусологии, Vol 67, Iss 4, Pp 341-350 (2022)
Introduction. Yellow fever (YF) remains one of the most common natural focal infectious diseases in the world. In connection with the increasing tourist flow to countries endemic for YF, the discovery of stable populations of Aedes aegypti and Ae. al
Externí odkaz:
https://doaj.org/article/32beed8081f640f1b8f6509efd3118c5
Autor:
Alexander B. Ryzhikov, Evgeny A. Ryzhikov, Marina P. Bogryantseva, Svetlana V. Usova, Elena A. Nechaeva, Elena D. Danilenko, Stepan A. Pyankov, Andrey S. Gudymo, Anastasiya A. Moiseeva, Galina S. Onkhonova, Oleg V. Pyankov, Ekaterina S. Sleptsova, Nikita V. Lomakin, Veronika S. Vasilyeva, Mikhail V. Tulikov, Vitaly G. Gusarov, Andrey A. Pulin, Maria A. Balalaeva, Svetlana B. Erofeeva, Stanislav A. Terpigorev, Olga A. Rychkova, Ivan M. Petrov, Viktoriia Y. Delian, Vladimir V. Rafalskiy, Sergey V. Tyranovets, Elena V. Gavrilova, Rinat A. Maksyutov
Publikováno v:
Vaccines, Vol 11, Iss 5, p 998 (2023)
The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthetic pept
Externí odkaz:
https://doaj.org/article/200e423720e04b339bd6ba8dcab07260
Autor:
Sergei N. Shchelkunov, Stanislav N. Yakubitskiy, Alexander A. Sergeev, Ekaterina V. Starostina, Ksenia A. Titova, Stepan A. Pyankov, Galina A. Shchelkunova, Mariya B. Borgoyakova, Alexey M. Zadorozhny, Lyubov A. Orlova, Denis N. Kisakov, Larisa I. Karpenko
Publikováno v:
Viruses, Vol 14, Iss 7, p 1453 (2022)
The conventional live smallpox vaccine based on the vaccinia virus (VACV) cannot be widely used today because it is highly reactogenic. Therefore, there is a demand for designing VACV variants possessing enhanced immunogenicity, making it possible to
Externí odkaz:
https://doaj.org/article/7c9855202119445588ad2769503afd31
Autor:
Sergei N. Shchelkunov, Aleksander A. Sergeev, Ksenia A. Titova, Stepan A. Pyankov, Ekaterina V. Starostina, Maria B. Borgoyakova, Lubov A. Kisakova, Denis N. Kisakov, Larisa I. Karpenko, Stanislav N. Yakubitskiy
Publikováno v:
Acta Naturae. 14:111-118
The spread of the monkeypox virus infection among humans in many countries outside of Africa, which started in 2022, is now drawing the attention of the medical and scientific communities to the fact that immunization against this infection is sorely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4c2d7ecf0f4e98ee2819c35ff48794c
https://doi.org/10.32607/actanaturae.11857
https://doi.org/10.32607/actanaturae.11857
Autor:
Sergei N. Shchelkunov, Alexander A. Sergeev, Stanislav N. Yakubitskiy, Ksenia A. Titova, Stepan A. Pyankov, Irina V. Kolosova, Ekaterina V. Starostina, Mariya B. Borgoyakova, Alexey M. Zadorozhny, Denis N. Kisakov, Irina S. Shulgina, Larisa I. Karpenko
Publikováno v:
Viruses, Vol 13, Iss 8, p 1631 (2021)
Mass vaccination has played a critical role in the global eradication of smallpox. Various vaccinia virus (VACV) strains, whose origin has not been clearly documented in most cases, have been used as live vaccines in different countries. These VACV s
Externí odkaz:
https://doaj.org/article/9724a2bc6d794a6287d7840378ce7ea5
Autor:
Sergei N. Shchelkunov, Stanislav N. Yakubitskiy, Kseniya A. Titova, Stepan A. Pyankov, Alexander A. Sergeev
Publikováno v:
Pathogens, Vol 10, Iss 3, p 377 (2021)
Following the WHO announcement of smallpox eradication, discontinuation of smallpox vaccination with vaccinia virus (VACV) was recommended. However, interest in VACV was soon renewed due to the opportunity of genetic engineering of the viral genome b
Externí odkaz:
https://doaj.org/article/730a3da100cd4226bfaea805f9110e4f
Autor:
Sergei N. Shchelkunov, Stanislav N. Yakubitskiy, Alexander A. Sergeev, Alexei S. Kabanov, Tatiana V. Bauer, Leonid E. Bulychev, Stepan A. Pyankov
Publikováno v:
Viruses, Vol 12, Iss 8, p 795 (2020)
The mass smallpox vaccination campaign has played a crucial role in smallpox eradication. Various strains of the vaccinia virus (VACV) were used as a live smallpox vaccine in different countries, their origin being unknown in most cases. The VACV str
Externí odkaz:
https://doaj.org/article/cd15bccc45574a50a2ab325a68c01759
Autor:
Ekaterina I. Krivosheina, Mikhail Y. Kartashov, Ekaterina V. Naidenova, Nikita D. Ushkalenko, Stepan A. Pyankov, Vladimir A. Ternovoi, Valery B. Loktev
Publikováno v:
Voprosy virusologii. 67(4)
Introduction. Yellow fever (YF) remains one of the most common natural focal infectious diseases in the world. In connection with the increasing tourist flow to countries endemic for YF, the discovery of stable populations of Aedes aegypti and Ae. al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f78595f9093d3fd7e07c746e86c886a
https://pubmed.ncbi.nlm.nih.gov/36097715
https://pubmed.ncbi.nlm.nih.gov/36097715
Autor:
Marina P. Bogryantseva, Evgenii А. Ryzhikov, Polina Yu Torzhkova, Denis V. Antonets, Natal’ya V Danil’chenko, Ivan M. Susloparov, Нечаева Елена Августовна (Ru), Galina S. Onkhonova, T. V. Tregubchak, Stepan A. Pyankov, Andrei S. Gudymo, Aleksandr B Ryzhikov, Ilnaz R. Imatdinov, Rinat A. Maksyutov, E. D. Danilenko, Sergei A. Bodnev, Elena V. Gavrilova, Ekaterina S. Sleptsova, Anastasiya A. Moiseeva, Vladimir N. Petrov, Olga G. Pyankova, Oleg V. Pyankov, Oleg S. Taranov, E. A. Nechaeva
Publikováno v:
Annals of the Russian academy of medical sciences. 76:5-19
Background: In 2020, the pandemic caused by novel coronavirus infection has become one of the most critical global health challenges during the past century. The lack of a vaccine, as the most effective way to control the novel infection, has prompte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::697278b8262a88fca979f7c5b6c75ae6
https://doi.org/10.15690/vramn1528
https://doi.org/10.15690/vramn1528
Autor:
E. A. Nechaeva, Z. I. Ginko, S. V. Usova, T. V. Tregubchak, Е. А. Ryzhikov, Andrei S. Gudymo, Rinat A. Maksyutov, E. S. Sleptsova, Marina P. Bogryantseva, A. A. Moiseeva, E. D. Danilenko, Oleg V. Pyankov, N. N. Ryndyuk, P. Yu. Torzhkova, Olga G. Pyankova, Elena V. Gavrilova, Galina S. Onkhonova, D. V. Antonec, Alexander B. Ryzhikov, V. I. Kuzubov, Sergei A. Bodnev, Stepan A. Pyankov, V. N. Petrov
Publikováno v:
Infekciâ i Immunitet, Vol 11, Iss 2, Pp 283-296 (2021)
Vaccination of the population is one of the most effective countermeasures in responding to the pandemic caused by novel coronavirus infection. Therefore, scientists all over the world have been working to develop effective and safe vaccines. We have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c10ef0ef4e781f89cac1b70b17f234
https://doi.org/10.15789/2220-7619-asb-1699
https://doi.org/10.15789/2220-7619-asb-1699